Advertisements
key calls

Key Calls (Thursday): Upgrades, Downgrades & Initiations

Are your stocks on the list?

Via Bloomberg

upgrade

  • Acceleron (XLRN) raised to buy at Citi
  • Estee Lauder (EL) raised to overweight at Piper Jaffray, PT $95
  • Exxon (XOM) raised to neutral at Credit Suisse
  • Sarepta (SRPT) raised to outperform at Leerink, PT $47
  • Seaspan (SSW) raised to neutral at JPMorgan, PT $8
  • WSP Global (WSP CN) raised to buy at Desjardins, PT C$52
  • Windstream (WIN) raised to hold at Jefferies, PT $7.50

downgrade

  • American Eagle (AEO) cut to neutral at BofAML, PT $15
  • Apache (APA) cut to underweight at Barclays, PT $50
  • Camping World Holdings (CWH) cut to sector weight at Keybanc
  • Dycom Industries (DY) cut to neutral at DA Davidson
  • Golden Ocean (GOGL) cut to buy at Swedbank, PT NOK67
  • Idex (IEX) cut to neutral at Janney
  • Kaman (KAMN) cut to neutral at Longbow
  • Kite Pharma (KITE) cut to neutral at Citi
  • RAIT Financial Trust (RAS) cut to hold at Deutsche Bank
  • SunOpta (SOY CN) cut to hold at Wunderlich
  • Time Warner (TWX) cut to hold at Loop Capital, PT $107.50
  • TripAdvisor (TRIP) cut to neutral at Piper Jaffray, PT $47
  • VimpelCom (VIP) cut to market perform at Renaissance Capital

initiation

  • Acceleron (XLRN) rated new buy at Nomura
  • Alexion (ALXN) rated new buy at Nomura
  • Ameriprise (AMP) rated new outperform at William Blair
  • Autoliv (ALV) rated new neutral at Mizuho, PT $115
  • B2Gold (BTO CN) reinstated buy at BofAML, PT C$5.20
  • Ball (BLL) rated new neutral at Goldman, PT $80
  • BioMarin (BMRN) rated new neutral at Nomura
  • Biogen (BIIB) rated new buy at Nomura, PT $345
  • Celadon Group (CGI) rated new buy at Aegis, PT $15
  • Cellectis (ALCLS FP) rated new buy at Nomura
  • Cogent Comms (CCOI) rated new neutral at Goldman, PT $43
  • CytomX (CTMX) rated new buy at Nomura
  • DaVita (DVA) re-initiated market perform at Bernstein, PT $68.50
  • Dalradian Resources (DNA CN) rated new buy at Eight Capital, PT C$1.70
  • Five Prime (FPRX) rated new buy at Nomura
  • Galapagos (GLPG NA) rated new buy at Nomura
  • Global Blood (GBT) rated new buy at Nomura
  • Incyte (INCY) rated new buy at Nomura
  • Interpublic (IPG) rated new buy at BofAML, PT $28
  • MacroGenics (MGNX) rated new buy at Nomura
  • Mobileye (MBLY) rated new neutral at Mizuho, PT $50
  • Nemaska Lithium (NMX CN) rated new outperform at National Bank
  • Omnicom (OMC) rated new neutral at BofAML, PT $91
  • PRA Group (PRAA) resumed overweight at First Analysis
  • Parker-Hannifin (PH) resumed overweight at Morgan Stanley, PT $180
  • Prothena (PRTA) rated new buy at Nomura
  • Regency Centers (REG) resumed neutral at Citi
  • Sarepta (SRPT) rated new buy at Nomura
  • Shopify (SHOP CN) rated new outperform at National Bank, PT $80
  • Splunk (SPLK) rated new outperform at Bernstein, PT $72
  • Syndax Pharmaceuticals (SNDX) rated new buy at Nomura
  • Voyager Therapeutics (VYGR) rated new buy at Nomura
  • Xencor (XNCR) rated new neutral at Nomura
  • Xilinx (XLNX) rated new neutral at Mizuho, PT $64
Advertisements

0 comments on “Key Calls (Thursday): Upgrades, Downgrades & Initiations

Speak On It

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Skip to toolbar